Related Experiment Videos
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine
C Bartel1, N Obermüller, M J Rummel
1Department of Nephrology, University Hospital of Frankfurt/Main, Germany.
Abstract:
In a 56-year-old white male patient, a membranoproliferative glomerulonephritis Type I was diagnosed after a 12-month history of low grade B cell lymphoma (Binet A). HIV, Hepatitis B and C serology were negative. Due to an impairment of renal function despite chemotherapy with COP, an immunochemotherapy consisting of rituximab (6 cycles) and bendamustine (4 cycles) was given. This therapeutic approach caused a complete remission of the nephrotic syndrome. Renal function and arterial hypertension improved markedly. In addition, urinary sediment became normal and proteinuria disappeared completely.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Respiratory Syncytial Virus Disease
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids